Literature DB >> 26524632

Preserved recovery of cardiac function following ischemia-reperfusion in mice lacking SIRT3.

Christoph Koentges1, Katharina Pfeil1, Maximilian Meyer-Steenbuck1, Achim Lother1,2, Michael M Hoffmann3, Katja E Odening1, Lutz Hein2, Christoph Bode1, Heiko Bugger1.   

Abstract

Lack of the mitochondrial deacetylase sirtuin 3 (SIRT3) impairs mitochondrial function and increases the susceptibility to induction of the mitochondrial permeability transition pore. Because these alterations contribute to myocardial ischemia-reperfusion (IR) injury, we hypothesized that SIRT3 deficiency may increase cardiac injury following myocardial IR. Hearts of 10-week-old mice were perfused in the isolated working mode and subjected to 17.5 min of global no-flow ischemia, followed by 30 min of reperfusion. Measurements before ischemia revealed a decrease in cardiac power (-20%) and rate pressure product (-15%) in SIRT3(-/-) mice. Mitochondrial state 3 respiration (-15%), ATP synthesis (-39%), and ATP/O ratios (-29%) were decreased in hearts of SIRT3(-/-) mice. However, percent recovery of cardiac power (WT 94% ± 9%; SIRT3(-/-) 89% ± 9%) and rate pressure product (WT 89% ± 16%; SIRT3(-/-) 96% ± 3%) following IR was similar in both groups. Myocardial infarct size was not increased in SIRT3(-/-) mice following permanent ligation of the left anterior descending coronary artery (LAD). Left ventricular pressure and dP/dtmax, and mitochondrial respiration and ATP synthesis were not different between groups following LAD ligation. Thus, despite pre-existing defects in cardiac function and mitochondrial respiratory capacity in SIRT3(-/-) mice, SIRT3 deficiency does not additionally impair cardiac function following IR or following myocardial infarction.

Entities:  

Keywords:  SIRT3; cardiac function; cœur; fonction cardiaque; heart; infarctus du myocarde; ischemia–reperfusion; ischémie reperfusion; mitochondria; mitochondrie; myocardial infarction; sirtuin; sirtuine

Mesh:

Substances:

Year:  2015        PMID: 26524632     DOI: 10.1139/cjpp-2015-0152

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  18 in total

1.  Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.

Authors:  Guoliang Meng; Jieqiong Liu; Shangmin Liu; Qiuyi Song; Lulu Liu; Liping Xie; Yi Han; Yong Ji
Journal:  Br J Pharmacol       Date:  2017-07-06       Impact factor: 8.739

Review 2.  Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease.

Authors:  Xiaochen He; Heng Zeng; Jian-Xiong Chen
Journal:  J Cell Physiol       Date:  2018-08-21       Impact factor: 6.384

Review 3.  Mitochondrial sirtuins in the heart.

Authors:  Heiko Bugger; Constantin N Witt; Christoph Bode
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

4.  SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

Authors:  Xavier Palomer; M Silvia Román-Azcona; Javier Pizarro-Delgado; Ana Planavila; Francesc Villarroya; Brenda Valenzuela-Alcaraz; Fátima Crispi; Álvaro Sepúlveda-Martínez; Irene Miguel-Escalada; Jorge Ferrer; J Francisco Nistal; Raquel García; Mercy M Davidson; Emma Barroso; Manuel Vázquez-Carrera
Journal:  Signal Transduct Target Ther       Date:  2020-02-28

Review 5.  Sirtuins and the circadian clock interplay in cardioprotection: focus on sirtuin 1.

Authors:  Sanjeev Kumar Soni; Priyoneel Basu; Muniyandi Singaravel; Ramaswamy Sharma; Seithikurippu R Pandi-Perumal; Daniel P Cardinali; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2021-01-03       Impact factor: 9.261

6.  The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.

Authors:  Philipp Diehl; Daniel S Gaul; Jonas Sogl; Ulrike Flierl; Darren Henstridge; Juergen Pahla; Heiko Bugger; Maximilian Y Emmert; Frank Ruschitzka; Christoph Bode; Thomas F Lüscher; Martin Moser; Christian M Matter; Karlheinz Peter; Stephan Winnik
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

7.  High Sensitivity of SIRT3 Deficient Hearts to Ischemia-Reperfusion Is Associated with Mitochondrial Abnormalities.

Authors:  Rebecca M Parodi-Rullán; Xavier Chapa-Dubocq; Pedro J Rullán; Sehwan Jang; Sabzali Javadov
Journal:  Front Pharmacol       Date:  2017-05-16       Impact factor: 5.810

Review 8.  SIRT3 in Cardiac Physiology and Disease.

Authors:  Christoph Koentges; Christoph Bode; Heiko Bugger
Journal:  Front Cardiovasc Med       Date:  2016-10-13

9.  CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia-reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation.

Authors:  Xiaolin Wang; Yuanqiang Dai; Xiaoxiu Zhang; Ke Pan; Yu Deng; Jiafeng Wang; Tao Xu
Journal:  Cancer Biol Ther       Date:  2020-11-26       Impact factor: 4.742

Review 10.  SIRT3: A New Regulator of Cardiovascular Diseases.

Authors:  Wei Sun; Caixia Liu; Qiuhui Chen; Ning Liu; Youyou Yan; Bin Liu
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.